Norway, Oct. 15 -- Photocure ASA, the Bladder Cancer Company, announces that it has entered into a partnership with Intelligent Scopes Corporation (ISC) to develop Artificial Intelligence (AI) software with blue light cystoscopy (BLC[(R)]). Initial testing shows promising performance results.Photocure and ISC have signed a development agreement on AI software and BLC for the detection of bladder tumors. Photocure is a pioneer in the bladder cancer diagnostics market with its Hexvix[(R)]/Cysview[(R)] products, supported by robust clinical evidence and treatment guidelines. ISC, based in the U.S., is a subsidiary of Claritas HealthTech Limited, based in the UK. Claritas and its affiliates, together with ISC, develop leading endoscopy solution...